$ cat ./records/northern-nigerias-polio-vaccine-boycott-sets-back-the-gates-backe-2003.txt
Northern Nigeria's Polio Vaccine Boycott Sets Back the Gates-Backed Eradication Drive
[RECORD.TXT] · cat --full
A major setback struck the global polio-eradication campaign — which the Gates Foundation funds more heavily than almost any other donor — when several northern Nigerian states boycotted the oral polio vaccine from 2003 to 2004. Influential local figures spread false, unfounded rumors that the vaccine was contaminated to cause infertility or spread HIV; distrust was compounded by an earlier Pfizer drug-trial scandal in Kano. The roughly year-long boycott let polio surge in Nigeria and re-infect more than a dozen previously polio-free countries — a stark example of how misinformation can derail even well-funded global-health efforts.
Source: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0040073
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Microsoft Pays $23.25 Million to Settle Antitrust Claims by BeOS Maker Be Inc.
Next →
Microsoft pays its first dividend to shareholders
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.